Manufacturing / Biological Products, Except Diagnostic Substances
Maze Therapeutics, Inc.
MAZE
$30.44
+$0.83 (+2.82%)
Price as of Aug 25, 2026 17:59 UTC
1.7 B
Market Cap (Small Cap)
Nov 02
Next Earnings
Options Heat Map
Delta-risk grid for MAZE options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
71 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Bernstein Harold | Exercise | 16,142 | $0 | |
| Aug 13, 2026 | Bernstein Harold | Sell | 16,142 | $445,621 | |
| Aug 13, 2026 | Bernstein Harold | Exercise | 16,142 | $168,200 | |
| Aug 03, 2026 | Coloma Jason V | Sell | 1,604 | $43,445 | |
| Aug 03, 2026 | Coloma Jason V | Sell | 30,304 | $809,541 | |
| Aug 03, 2026 | Coloma Jason V | Sell | 154 | $4,172 | |
| Aug 03, 2026 | Coloma Jason V | Sell | 2,439 | $65,157 | |
| Jul 29, 2026 | Dandekar Atul | Exercise | 7,500 | $0 | |
| Jul 29, 2026 | Dandekar Atul | Sell | 400 | $11,156 | |
| Jul 29, 2026 | Dandekar Atul | Sell | 7,100 | $193,875 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 18, 2026 | Q2 2026 | -$0.75 | |||
| Mar 31, 2026 | Q1 2026 | -$0.56 | -$0.45 | +19.1% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.73 | -$0.65 | +10.7% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.72 | -$0.66 | +8.7% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.87 | -$0.77 | +11.8% | Beat |
Track MAZE with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for MAZE and your entire portfolio.